ENDLOS-TURBO CALL - ELI LILLY & CO | Delayed Deutsche Boerse AG 03:34:47 2023-11-09 pm EST | ||
| 15.29 EUR | -17.49% |
|
| 1 month | +7.90% | ||
| 3 months | +52.29% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
ELI LILLY AND COMPANY
Latest news about ELI LILLY AND COMPANY
Static data
| Product type | Knock-Out without Stop Loss |
|---|---|
| Buy / Sell | CALL |
| Underlying | ELI LILLY AND COMPANY |
| Issuer | DZ BANK |
| WKN | DJ1GRH |
| ISIN | DE000DJ1GRH9 |
| Date issued | 2023-05-05 |
| Strike | 425.9 $ |
| Maturity | Unlimited |
| Parity | 10 : 1 |
| Emission price | 2.24 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 19.08 € |
|---|---|
| Lowest since issue | 1.05 € |
Company Profile
Eli Lilly and Company is one of the world's leading pharmaceutical groups. Net sales break down by therapeutic field as follows:
- endocrinology (57.7%): products for treating osteoporosis, diabetes, and growth problems;
- oncology (19.5%);
- immunology diseases (11.1%);
- neurology (8.4%): primarily drugs used in treating depression and schizophrenia;
- other (3.3%).
Net sales are distributed geographically as follows: the United States (63.9%), Europe (18.1%), Japan (4.9%), China (4.5%) and other (8.6%).
Sector
-
Consensus: Eli Lilly and Company
Sell
Buy
Mean consensus
BUY
Number of Analysts
28
Last Close Price
906.7
USD
Average target price
870
USD
Spread / Average Target
-4.05%
- Stock Market
- Certificates
- Certificat
